Paris, France

Christophe Daubié

This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christophe Daubié. Retrieved from https://idiyas.com/inventor/christophe-daubiandeacute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christophe Daubié: Innovator in Antimicrobial Agents

Introduction

Christophe Daubié is a notable inventor based in Paris, France. He has made significant contributions to the field of antimicrobial agents through his innovative work. With a total of two patents to his name, Daubié has established himself as a key figure in pharmaceutical research.

Latest Patents

His latest patents include the development of quinolylpropylpiperidine derivatives, which are described as useful antimicrobial agents. The preparation of these derivatives is also detailed in his patents, showcasing their potential applications in combating microbial infections.

Career Highlights

Daubié is currently associated with Aventis Pharma S.A., where he continues to advance his research in pharmaceuticals. His work has been instrumental in the development of new compounds that can enhance the efficacy of antimicrobial treatments.

Collaborations

Throughout his career, Daubié has collaborated with esteemed colleagues such as Serge Mignani and Jean-Luc Malleron. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Christophe Daubié's contributions to the field of antimicrobial agents through his patents and collaborations highlight his importance as an inventor. His work continues to influence the pharmaceutical industry and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…